[Obstruction of the urethral conduct following implantation of the endoprosthesis Urolume: therapeutic management].
The introduction of self-expandable urethral endoprostheses for the management of relapsing urethral stenosis has required the development of a minimally invasive therapeutical approach of widespread acceptance by the urological community. The reason for its success is the simplicity of implantation and the low rate of complications up to date. This paper reports on a patient carrying a ¿Urolume¿ urethral endoprosthesis for a relapsing bulbar urethral stenosis, which two years after implantation presents re-stenosis secondary to endoluminal inflammatory tissue growth. After two failure endoscopic resections, endoscopic removal of the prosthesis was required. Currently the patient carries a ¿Urocoil¿ spiral endoprosthesis to avoid tissular reaction. The therapeutical aspects found in the literature are reviewed, emphasizing the need of follow-up to detect complications, to improve indications and to select those patients that may be candidates for this treatment.
Pereira Arias
J G
JG
Servicio de Urología, Hospital de Galdakao, Vizcaya.
Maraña Fernandez
M
M
Escobal Tamayo
V
V
Ibarluzea González
J G
JG
Bernuy Malfaz
C
C
D000328:Adult; D006801:Humans; D008297:Male; D019736:Prostheses and Implants / Q000009:adverse effects*; D014524:Urethral Obstruction / Q000209:etiology* / Q000628:therapy
Obliteración de la luz uretral tras implante de endoprotesis urolume: manejo terapéutico.